Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Int J Mol Sci. 2022 Oct 14;23(20):12285. doi: 10.3390/ijms232012285.
Although all cells in the human body are made of the same DNA, these cells undergo differentiation and behave differently during development, through integration of external and internal stimuli via 'specific mechanisms.' Epigenetics is one such mechanism that comprises DNA/RNA, histone modifications, and non-coding RNAs that regulate transcription without changing the genetic code. The discovery of the first Polycomb mutant phenotype in Drosophila started the study of epigenetics more than 80 years ago. Since then, a considerable number of Polycomb Group (PcG) genes in Drosophila have been discovered to be preserved in mammals, including humans. PcG proteins exert their influence through gene repression by acting in complexes, modifying histones, and compacting the chromatin within the nucleus. In this article, we discuss how our knowledge of the PcG repression mechanism in Drosophila translates to human communicable disease research.
虽然人体所有细胞均由相同的 DNA 构成,但这些细胞在发育过程中会通过“特定机制”整合内外刺激而发生分化并表现出不同的行为。表观遗传学就是这样一种机制,它包括 DNA/RNA、组蛋白修饰和非编码 RNA,这些机制可以在不改变遗传密码的情况下调节转录。80 多年前,在果蝇中发现第一个 Polycomb 突变表型,这一发现推动了对表观遗传学的研究。此后,在哺乳动物(包括人类)中发现了相当数量的果蝇 Polycomb 组(PcG)基因得以保存。PcG 蛋白通过复合物作用、修饰组蛋白以及压缩核内染色质来发挥其抑制基因的作用。在本文中,我们将讨论我们对果蝇 PcG 抑制机制的了解如何转化为人类传染病研究。